Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Korea Otsuka Pharmaceutical Co., Ltd. | INDUSTRY |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The aim of the study is to investigate the efficacy and safety of aripiprazole in patients with first episode psychosis.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| drug | Other |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Aripiprazole | Drug | 6 week prospective study |
|
| Measure | Description | Time Frame |
|---|---|---|
| Symptoms assessment by objective rating scales | PANSS total score, SANS, CGI | week 1 |
| Symptoms assessment by objective rating scales | PANSS total score, SANS, CGI | week 2 |
| Symptoms assessment by objective rating scales | PANSS total score, SANS, CGI | week 3 |
| Symptoms assessment by objective rating scales | PANSS total score, SANS, CGI | week 4 |
| Symptoms assessment by objective rating scales | PANSS total score, SANS, CGI | week 6 |
| Measure | Description | Time Frame |
|---|---|---|
| Assessment of adverse events by objective rating scales and self report scales | NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS | week 1 |
| Assessment of adverse events by objective rating scales and self report scales |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Department of Psychiatry, Kangwon National University College of Medicine | Chunchon | South Korea | ||||
Not provided
| ID | Term |
|---|---|
| D000068180 | Aripiprazole |
| ID | Term |
|---|---|
| D010879 | Piperazines |
| D006573 | Heterocyclic Compounds, 1-Ring |
| D006571 | Heterocyclic Compounds |
| D015363 | Quinolones |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS
| week 2 |
| Assessment of adverse events by objective rating scales and self report scales | NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS, AIMS | week 4 |
| Assessment of adverse events by objective rating scales and self report scales | NIDSS(Neuroleptic induced deficit syndrome scale), BAS, SAS, AIMS, Lipid profile | week 6 |
| Department of Psychiatry, Kyungpook national University School of Medicine |
| Daegu |
| South Korea |
| Department of Psychiatry, Eulji University, School of Medicine | Daejeon | South Korea |
| Department of Psychiatry, Kongju National Hospital | Gongju | South Korea |
| Department of Psychiatry, Inje University College of Medicine, Ilsan Paik Hospital | Goyang | South Korea |
| Department of Psychiatry, Chonnam National University Medical School | Hwasun | South Korea |
| Department of Psychiatry, College of Medicine, Won-Kwang University | Iksan | South Korea |
| Department of Psychiatry, Gachon University of Medicine and Science | Incheon | South Korea |
| Department of Psychiatry, Chonbuk national University Hospital | Jeonju | 561-712 | South Korea |
| Department of Psychiatry, Myongji Hospital Kwandong Uni. college of Medicine | Koyang | South Korea |
| St. John of God Neuropsychiatric Hospital | Kwangju | South Korea |
| department of Neuropsychiatry. Dong-Eui University Medical Center | Pusan | South Korea |
| Department of Neuropsychiatry, Soonchunhyang University Hospital | Seoul | South Korea |
| D011804 |
| Quinolines |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |